Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli Infections | 21 | 2015 | 47 | 0.990 |
Why?
|
| Escherichia coli | 20 | 1999 | 368 | 0.870 |
Why?
|
| Catheterization, Central Venous | 2 | 2018 | 89 | 0.870 |
Why?
|
| Cross Infection | 6 | 2020 | 195 | 0.820 |
Why?
|
| Diarrhea | 16 | 1999 | 63 | 0.730 |
Why?
|
| Catheter-Related Infections | 1 | 2018 | 43 | 0.620 |
Why?
|
| Infection Control | 1 | 2018 | 101 | 0.590 |
Why?
|
| Bacterial Adhesion | 9 | 1999 | 33 | 0.580 |
Why?
|
| Sepsis | 2 | 2018 | 233 | 0.520 |
Why?
|
| Peyer's Patches | 8 | 1997 | 10 | 0.480 |
Why?
|
| Fimbriae, Bacterial | 8 | 1999 | 13 | 0.430 |
Why?
|
| Staphylococcal Infections | 6 | 2015 | 156 | 0.420 |
Why?
|
| Prosthesis-Related Infections | 2 | 2008 | 70 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 8 | 2020 | 1026 | 0.360 |
Why?
|
| Genes, Bacterial | 4 | 1999 | 40 | 0.330 |
Why?
|
| Disinfectants | 3 | 2013 | 61 | 0.300 |
Why?
|
| Rabbits | 25 | 1999 | 509 | 0.300 |
Why?
|
| Joint Prosthesis | 1 | 2008 | 48 | 0.300 |
Why?
|
| Arthroplasty, Replacement | 1 | 2008 | 48 | 0.300 |
Why?
|
| Influenza, Human | 1 | 2008 | 79 | 0.300 |
Why?
|
| Hospitals, Special | 1 | 2007 | 15 | 0.290 |
Why?
|
| Copper | 3 | 2013 | 149 | 0.290 |
Why?
|
| Long-Term Care | 1 | 2007 | 53 | 0.290 |
Why?
|
| Gram-Negative Bacteria | 1 | 2007 | 55 | 0.290 |
Why?
|
| Disaster Planning | 1 | 2008 | 105 | 0.290 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 72 | 0.280 |
Why?
|
| Nursing Staff, Hospital | 1 | 2007 | 62 | 0.280 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2007 | 62 | 0.280 |
Why?
|
| Bacteremia | 2 | 2007 | 155 | 0.270 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 445 | 0.260 |
Why?
|
| Disease Outbreaks | 3 | 2008 | 83 | 0.230 |
Why?
|
| Bacterial Infections | 3 | 2014 | 163 | 0.220 |
Why?
|
| Fomites | 2 | 2013 | 12 | 0.220 |
Why?
|
| Intensive Care Units | 2 | 2013 | 344 | 0.190 |
Why?
|
| Antimicrobial Stewardship | 1 | 2020 | 33 | 0.180 |
Why?
|
| Intestinal Mucosa | 6 | 1987 | 219 | 0.180 |
Why?
|
| Clostridium Infections | 1 | 2020 | 52 | 0.180 |
Why?
|
| Lymphoid Tissue | 3 | 1984 | 30 | 0.160 |
Why?
|
| Hospitals | 3 | 2015 | 265 | 0.160 |
Why?
|
| Humans | 28 | 2020 | 68618 | 0.140 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 166 | 0.130 |
Why?
|
| Environmental Microbiology | 2 | 2013 | 25 | 0.130 |
Why?
|
| Antibodies, Bacterial | 7 | 1987 | 90 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2015 | 62 | 0.130 |
Why?
|
| Dysentery, Bacillary | 4 | 1996 | 8 | 0.120 |
Why?
|
| Staphylococcus aureus | 4 | 2010 | 175 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2015 | 83 | 0.120 |
Why?
|
| Immunoglobulin A, Secretory | 3 | 1987 | 6 | 0.120 |
Why?
|
| Endocarditis, Bacterial | 3 | 2010 | 32 | 0.120 |
Why?
|
| Retrospective Studies | 4 | 2018 | 7277 | 0.120 |
Why?
|
| Disinfection | 2 | 2013 | 112 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1553 | 0.120 |
Why?
|
| Risk Factors | 2 | 2018 | 5731 | 0.120 |
Why?
|
| Ileum | 5 | 1997 | 28 | 0.110 |
Why?
|
| Animals | 33 | 1999 | 20881 | 0.110 |
Why?
|
| Middle Aged | 7 | 2018 | 21147 | 0.100 |
Why?
|
| Epithelium | 6 | 1997 | 172 | 0.100 |
Why?
|
| Antigens, Bacterial | 3 | 1987 | 54 | 0.100 |
Why?
|
| Microscopy, Electron | 7 | 1996 | 351 | 0.100 |
Why?
|
| Musculoskeletal Diseases | 1 | 2012 | 45 | 0.100 |
Why?
|
| Intestines | 5 | 1995 | 114 | 0.090 |
Why?
|
| Virulence | 4 | 1999 | 51 | 0.090 |
Why?
|
| Shigella flexneri | 4 | 1996 | 9 | 0.090 |
Why?
|
| Penicillin Resistance | 1 | 1990 | 12 | 0.090 |
Why?
|
| Methicillin | 1 | 1990 | 11 | 0.090 |
Why?
|
| Actins | 1 | 1991 | 249 | 0.090 |
Why?
|
| Bacterial Toxins | 3 | 1985 | 50 | 0.090 |
Why?
|
| Female | 11 | 2018 | 38074 | 0.090 |
Why?
|
| Entamoeba histolytica | 7 | 1985 | 9 | 0.080 |
Why?
|
| Male | 10 | 2018 | 37321 | 0.080 |
Why?
|
| Milk | 2 | 1987 | 43 | 0.080 |
Why?
|
| Adhesins, Bacterial | 2 | 1999 | 13 | 0.080 |
Why?
|
| World Health Organization | 1 | 2008 | 53 | 0.080 |
Why?
|
| Debridement | 1 | 2008 | 55 | 0.080 |
Why?
|
| Enterobacteriaceae | 1 | 1988 | 29 | 0.080 |
Why?
|
| Cephalosporins | 1 | 1988 | 59 | 0.080 |
Why?
|
| Aged | 7 | 2015 | 14862 | 0.070 |
Why?
|
| Needlestick Injuries | 1 | 2007 | 10 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 349 | 0.070 |
Why?
|
| Sentinel Surveillance | 1 | 2007 | 20 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 45 | 0.070 |
Why?
|
| Education, Nursing, Continuing | 1 | 2007 | 27 | 0.070 |
Why?
|
| Knee Prosthesis | 1 | 2007 | 64 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1988 | 133 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2014 | 2358 | 0.070 |
Why?
|
| Hip Prosthesis | 1 | 2007 | 85 | 0.070 |
Why?
|
| Reoperation | 1 | 2008 | 467 | 0.070 |
Why?
|
| Cytotoxins | 6 | 1984 | 23 | 0.070 |
Why?
|
| DNA, Bacterial | 2 | 1999 | 150 | 0.070 |
Why?
|
| Microvilli | 3 | 1997 | 22 | 0.070 |
Why?
|
| Adult | 7 | 2020 | 21403 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2008 | 211 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 4848 | 0.070 |
Why?
|
| Plasmids | 2 | 1995 | 258 | 0.060 |
Why?
|
| Immunoglobulin A | 3 | 1987 | 79 | 0.060 |
Why?
|
| Immunoglobulin G | 7 | 1987 | 481 | 0.060 |
Why?
|
| South Carolina | 2 | 2007 | 2752 | 0.060 |
Why?
|
| Respiratory Tract Infections | 2 | 2015 | 91 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 1999 | 2550 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2014 | 7029 | 0.050 |
Why?
|
| Colony Count, Microbial | 2 | 2013 | 77 | 0.050 |
Why?
|
| Mycobacterium chelonae | 1 | 2001 | 9 | 0.050 |
Why?
|
| Clarithromycin | 1 | 2001 | 11 | 0.050 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2001 | 17 | 0.050 |
Why?
|
| Attachment Sites, Microbiological | 1 | 1981 | 1 | 0.050 |
Why?
|
| Lysogeny | 1 | 1981 | 4 | 0.050 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2001 | 37 | 0.050 |
Why?
|
| Chromatography, Gel | 4 | 1985 | 79 | 0.050 |
Why?
|
| Enterotoxins | 4 | 1985 | 40 | 0.050 |
Why?
|
| Base Sequence | 2 | 1999 | 1015 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 24 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 1447 | 0.040 |
Why?
|
| Research | 1 | 2020 | 214 | 0.040 |
Why?
|
| DNA Probes | 1 | 1999 | 57 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1999 | 50 | 0.040 |
Why?
|
| Multigene Family | 1 | 1999 | 93 | 0.040 |
Why?
|
| alpha-Fetoproteins | 2 | 1981 | 22 | 0.040 |
Why?
|
| Cecum | 3 | 1985 | 39 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 1997 | 25 | 0.040 |
Why?
|
| Listeriosis | 2 | 1974 | 7 | 0.040 |
Why?
|
| Amniotic Fluid | 1 | 1977 | 30 | 0.040 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1996 | 21 | 0.040 |
Why?
|
| Vancomycin | 2 | 2015 | 60 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 1996 | 65 | 0.030 |
Why?
|
| Penicillins | 1 | 2015 | 32 | 0.030 |
Why?
|
| Shiga Toxins | 2 | 1985 | 2 | 0.030 |
Why?
|
| Fluoroquinolones | 1 | 2015 | 49 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 107 | 0.030 |
Why?
|
| Teichoic Acids | 2 | 1985 | 7 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 1974 | 80 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 442 | 0.030 |
Why?
|
| Kanamycin | 1 | 1974 | 11 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1991 | 765 | 0.030 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 1974 | 8 | 0.030 |
Why?
|
| Plague | 1 | 1974 | 9 | 0.030 |
Why?
|
| HeLa Cells | 3 | 1991 | 237 | 0.030 |
Why?
|
| Respiratory System | 1 | 1974 | 28 | 0.030 |
Why?
|
| Fever | 1 | 1994 | 96 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1996 | 597 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2013 | 38 | 0.030 |
Why?
|
| Vancomycin Resistance | 1 | 2013 | 18 | 0.030 |
Why?
|
| Patients' Rooms | 1 | 2013 | 15 | 0.030 |
Why?
|
| Enterococcus | 1 | 2013 | 29 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2013 | 35 | 0.030 |
Why?
|
| Kinetics | 2 | 1987 | 1047 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1995 | 282 | 0.030 |
Why?
|
| Immunoglobulin M | 2 | 1985 | 172 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 92 | 0.030 |
Why?
|
| Child | 2 | 2020 | 6405 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 1991 | 37 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 334 | 0.020 |
Why?
|
| O Antigens | 2 | 1987 | 6 | 0.020 |
Why?
|
| Bacteria | 1 | 2012 | 193 | 0.020 |
Why?
|
| Disease Reservoirs | 1 | 1990 | 7 | 0.020 |
Why?
|
| Personnel, Hospital | 1 | 1990 | 19 | 0.020 |
Why?
|
| Southeastern United States | 1 | 2010 | 281 | 0.020 |
Why?
|
| Apoptosis | 1 | 1996 | 1641 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2010 | 174 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 1990 | 147 | 0.020 |
Why?
|
| Colon | 2 | 1981 | 168 | 0.020 |
Why?
|
| Immunodiffusion | 3 | 1985 | 19 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2012 | 340 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2279 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1603 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1988 | 70 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1987 | 93 | 0.020 |
Why?
|
| Pregnancy | 2 | 1987 | 2334 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2007 | 216 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1986 | 62 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 1426 | 0.020 |
Why?
|
| Signal Transduction | 1 | 1995 | 2689 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 1986 | 324 | 0.020 |
Why?
|
| Dysentery, Amebic | 1 | 1985 | 2 | 0.020 |
Why?
|
| Serotyping | 1 | 1985 | 16 | 0.020 |
Why?
|
| Species Specificity | 2 | 1996 | 303 | 0.020 |
Why?
|
| Vibrio parahaemolyticus | 1 | 1985 | 2 | 0.020 |
Why?
|
| Shigella dysenteriae | 1 | 1985 | 2 | 0.020 |
Why?
|
| Vibrio cholerae | 1 | 1985 | 6 | 0.020 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1985 | 9 | 0.020 |
Why?
|
| Salmonella Infections | 1 | 1985 | 11 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 1985 | 15 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1985 | 31 | 0.020 |
Why?
|
| Intestine, Small | 1 | 1985 | 89 | 0.020 |
Why?
|
| Listeria monocytogenes | 2 | 1974 | 15 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2007 | 1046 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 2 | 1974 | 32 | 0.010 |
Why?
|
| Staphylococcus epidermidis | 1 | 1983 | 12 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1984 | 236 | 0.010 |
Why?
|
| Mutation | 1 | 1989 | 1213 | 0.010 |
Why?
|
| Risk | 1 | 1985 | 563 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 5717 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 3705 | 0.010 |
Why?
|
| Lymph Nodes | 2 | 1974 | 258 | 0.010 |
Why?
|
| Clone Cells | 1 | 1982 | 67 | 0.010 |
Why?
|
| United States | 1 | 2014 | 7367 | 0.010 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2001 | 3 | 0.010 |
Why?
|
| Mice | 4 | 1985 | 8474 | 0.010 |
Why?
|
| Peptidyl Transferases | 1 | 2001 | 5 | 0.010 |
Why?
|
| Mast Cells | 1 | 1982 | 113 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2001 | 55 | 0.010 |
Why?
|
| alpha-Macroglobulins | 1 | 1981 | 8 | 0.010 |
Why?
|
| Point Mutation | 1 | 2001 | 97 | 0.010 |
Why?
|
| Appendix | 1 | 1981 | 9 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1981 | 31 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 226 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1981 | 61 | 0.010 |
Why?
|
| Guinea Pigs | 2 | 1978 | 124 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2001 | 223 | 0.010 |
Why?
|
| Epitopes | 1 | 1981 | 146 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1981 | 261 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1979 | 78 | 0.010 |
Why?
|
| Rectum | 1 | 1979 | 62 | 0.010 |
Why?
|
| Cholestyramine Resin | 1 | 1979 | 3 | 0.010 |
Why?
|
| Feces | 1 | 1979 | 88 | 0.010 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1978 | 4 | 0.010 |
Why?
|
| Intestine, Large | 1 | 1977 | 2 | 0.010 |
Why?
|
| Colitis | 1 | 1979 | 156 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1977 | 272 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1996 | 25 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 1996 | 79 | 0.010 |
Why?
|
| Actinin | 1 | 1995 | 9 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1995 | 41 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1995 | 100 | 0.010 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 1974 | 2 | 0.010 |
Why?
|
| Cell Migration Inhibition | 1 | 1974 | 8 | 0.010 |
Why?
|
| Goats | 1 | 1974 | 17 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1974 | 19 | 0.010 |
Why?
|
| Tyrosine | 1 | 1995 | 196 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1974 | 62 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 1083 | 0.010 |
Why?
|
| Pneumococcal Infections | 1 | 1974 | 30 | 0.010 |
Why?
|
| Capillaries | 1 | 1974 | 105 | 0.010 |
Why?
|
| Vietnam | 1 | 1974 | 36 | 0.010 |
Why?
|
| Yersinia pestis | 1 | 1974 | 6 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1974 | 228 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1974 | 144 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 852 | 0.010 |
Why?
|
| Pneumonia | 1 | 1974 | 110 | 0.010 |
Why?
|
| Phenotype | 1 | 1996 | 947 | 0.010 |
Why?
|
| Culture Media | 2 | 1984 | 155 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1985 | 507 | 0.010 |
Why?
|
| Cell Survival | 1 | 1974 | 901 | 0.010 |
Why?
|
| Cell Line | 1 | 1995 | 1752 | 0.010 |
Why?
|
| Macrophages | 1 | 1974 | 647 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1995 | 629 | 0.010 |
Why?
|
| Rats | 1 | 1977 | 5300 | 0.010 |
Why?
|
| Lung | 1 | 1974 | 849 | 0.010 |
Why?
|
| Cricetinae | 2 | 1979 | 262 | 0.000 |
Why?
|
| Immunoelectrophoresis, Two-Dimensional | 1 | 1985 | 2 | 0.000 |
Why?
|
| Coagulase | 1 | 1985 | 14 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1985 | 73 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1985 | 196 | 0.000 |
Why?
|
| Metalloproteins | 1 | 1984 | 3 | 0.000 |
Why?
|
| Lipopolysaccharides | 1 | 1986 | 455 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1984 | 52 | 0.000 |
Why?
|
| Metalloendopeptidases | 1 | 1984 | 67 | 0.000 |
Why?
|
| Heart Valve Diseases | 1 | 1985 | 123 | 0.000 |
Why?
|
| Cell Wall | 1 | 1983 | 21 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1983 | 57 | 0.000 |
Why?
|
| Heart Valve Prosthesis | 1 | 1985 | 222 | 0.000 |
Why?
|
| Methylcellulose | 1 | 1982 | 6 | 0.000 |
Why?
|
| Binding Sites, Antibody | 1 | 1982 | 34 | 0.000 |
Why?
|
| Hematopoiesis | 1 | 1982 | 108 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1982 | 91 | 0.000 |
Why?
|
| Spleen | 1 | 1982 | 301 | 0.000 |
Why?
|
| Bone Marrow Cells | 1 | 1982 | 217 | 0.000 |
Why?
|
| Isoelectric Focusing | 1 | 1981 | 42 | 0.000 |
Why?
|
| Chemical Fractionation | 1 | 1981 | 18 | 0.000 |
Why?
|
| Adolescent | 1 | 1974 | 8912 | 0.000 |
Why?
|
| Cattle | 1 | 1981 | 475 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1980 | 97 | 0.000 |
Why?
|
| Lincomycin | 1 | 1979 | 4 | 0.000 |
Why?
|
| Ammonium Sulfate | 1 | 1979 | 6 | 0.000 |
Why?
|
| Antitoxins | 1 | 1979 | 2 | 0.000 |
Why?
|
| Ultracentrifugation | 1 | 1979 | 10 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1979 | 14 | 0.000 |
Why?
|
| Clostridium | 1 | 1979 | 10 | 0.000 |
Why?
|
| Ultrafiltration | 1 | 1979 | 35 | 0.000 |
Why?
|
| Trypsin | 1 | 1979 | 64 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1979 | 66 | 0.000 |
Why?
|
| Gentamicins | 1 | 1979 | 68 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1979 | 358 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1978 | 43 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1979 | 618 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1982 | 2673 | 0.000 |
Why?
|
| Protein Binding | 1 | 1979 | 1027 | 0.000 |
Why?
|
| Proteins | 1 | 1979 | 474 | 0.000 |
Why?
|
| Time Factors | 1 | 1982 | 4655 | 0.000 |
Why?
|